How much revenue does ONE Bio make?

ONE Bio reported $52.30 million in revenue for fiscal year 2010, up 136.9% from $22.07 million in fiscal year 2009. In Q3 2011 revenue was $13.54 million.

What companies are similar to ONE Bio?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Baudax Bio, Inc. (BXRXQ), THE Flowr Corporation (FLWPF), Kaleido Biosciences, Inc. (KLDO), Ember Therapeutics, Inc. (EMBT).

ONE Bio Corp. (ONBI) Stock

About ONE Bio Corp.

ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-eco...

At a glance

ONE Bio reported revenue of $52.30 million for fiscal year 2010, up 136.9% from fiscal year 2009, and net income of $8.68 million. In Q3 2011 (the quarter ended September 30, 2011) revenue was $13.54 million, up 0.3% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2010.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.